Frontiers in Neuroscience-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1231567, encodeId=76a5123156ecb, content=这个一次修改大概给多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4e8152487, createdName=ms2000000736224610, createdTime=Sun Jul 10 00:25:25 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015566, encodeId=de9c1015566da, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：呼吸神经调控 经验分享：7月14日，投稿另一个杂志 7月21日，根据建议投稿本刊，开始Review 8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修 9月2日，Review结束 9月7日，接收。总体速度很快，编辑也很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8895545547, createdName=ms5000000031838810, createdTime=Wed Sep 08 09:08:33 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197480, encodeId=d401119e48076, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：神经退行性病变 经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86902507861, createdName=124b241fm93(暂无昵称), createdTime=Sat Feb 26 14:13:33 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200602, encodeId=dee112006026c, content=投稿2个半月，中间一次小修，accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39175593073, createdName=ms5000001819218664, createdTime=Tue Mar 08 16:15:06 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190195, encodeId=1c9e119019597, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：神经精神影像学 经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。 04 Feb 2022 Article accepted for publication. 03 Feb 2022 Review of Review Editor 2 finalized. 31 Jan 2022 Review of Review Editor 1 finalized. 29 Jan 2022 Corresponding Author ** re-submitted manuscript. 24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天 10 Nov 2021Corresponding Author ** submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220202/877149a0c31f433fb29e7e0ad849f4c0/076ec8880d2a478993563d85f21dae82.jpeg, createdBy=e98a2514828, createdName=pancs29, createdTime=Fri Feb 04 20:52:52 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196570, encodeId=6d7411965e069, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：已投8个月正在等消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c6b5611531, createdName=ms7000001135629356, createdTime=Wed Feb 23 21:49:27 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106075, encodeId=a63e11060e510, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106076, encodeId=af9e11060e6fb, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010343, encodeId=cbd01010343ad, content=求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5a2c5489227, createdName=ms9000001593769691, createdTime=Sun Aug 22 17:33:44 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007394, encodeId=4a2d100e394e3, content=偏重的研究方向：神经退行性疾病 经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bvIkMsUBo7h2qaicVFV7oRagNUor8OeO6wC7Zow0aSjmWbRwvGicHEmdWdPIibT5BcYT7DKhBGEQiagcgJ6v2XnH1A/132, createdBy=64172388588, createdName=Lewin, createdTime=Thu Aug 12 20:58:56 CST 2021, time=2021-08-12, status=1, ipAttribution=)]

2022-07-10 ms2000000736224610

这个一次修改大概给多长时间？

87 0

[GetPortalCommentsPageByObjectIdResponse(id=1231567, encodeId=76a5123156ecb, content=这个一次修改大概给多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4e8152487, createdName=ms2000000736224610, createdTime=Sun Jul 10 00:25:25 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015566, encodeId=de9c1015566da, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：呼吸神经调控 经验分享：7月14日，投稿另一个杂志 7月21日，根据建议投稿本刊，开始Review 8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修 9月2日，Review结束 9月7日，接收。总体速度很快，编辑也很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8895545547, createdName=ms5000000031838810, createdTime=Wed Sep 08 09:08:33 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197480, encodeId=d401119e48076, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：神经退行性病变 经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86902507861, createdName=124b241fm93(暂无昵称), createdTime=Sat Feb 26 14:13:33 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200602, encodeId=dee112006026c, content=投稿2个半月，中间一次小修，accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39175593073, createdName=ms5000001819218664, createdTime=Tue Mar 08 16:15:06 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190195, encodeId=1c9e119019597, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：神经精神影像学 经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。 04 Feb 2022 Article accepted for publication. 03 Feb 2022 Review of Review Editor 2 finalized. 31 Jan 2022 Review of Review Editor 1 finalized. 29 Jan 2022 Corresponding Author ** re-submitted manuscript. 24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天 10 Nov 2021Corresponding Author ** submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220202/877149a0c31f433fb29e7e0ad849f4c0/076ec8880d2a478993563d85f21dae82.jpeg, createdBy=e98a2514828, createdName=pancs29, createdTime=Fri Feb 04 20:52:52 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196570, encodeId=6d7411965e069, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：已投8个月正在等消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c6b5611531, createdName=ms7000001135629356, createdTime=Wed Feb 23 21:49:27 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106075, encodeId=a63e11060e510, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106076, encodeId=af9e11060e6fb, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010343, encodeId=cbd01010343ad, content=求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5a2c5489227, createdName=ms9000001593769691, createdTime=Sun Aug 22 17:33:44 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007394, encodeId=4a2d100e394e3, content=偏重的研究方向：神经退行性疾病 经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bvIkMsUBo7h2qaicVFV7oRagNUor8OeO6wC7Zow0aSjmWbRwvGicHEmdWdPIibT5BcYT7DKhBGEQiagcgJ6v2XnH1A/132, createdBy=64172388588, createdName=Lewin, createdTime=Thu Aug 12 20:58:56 CST 2021, time=2021-08-12, status=1, ipAttribution=)]

2021-09-08 ms5000000031838810

审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0
偏重的研究方向：呼吸神经调控
经验分享：7月14日，投稿另一个杂志
7月21日，根据建议投稿本刊，开始Review
8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修
9月2日，Review结束
9月7日，接收。总体速度很快，编辑也很nice

98 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1231567, encodeId=76a5123156ecb, content=这个一次修改大概给多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4e8152487, createdName=ms2000000736224610, createdTime=Sun Jul 10 00:25:25 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015566, encodeId=de9c1015566da, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：呼吸神经调控 经验分享：7月14日，投稿另一个杂志 7月21日，根据建议投稿本刊，开始Review 8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修 9月2日，Review结束 9月7日，接收。总体速度很快，编辑也很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8895545547, createdName=ms5000000031838810, createdTime=Wed Sep 08 09:08:33 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197480, encodeId=d401119e48076, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：神经退行性病变 经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86902507861, createdName=124b241fm93(暂无昵称), createdTime=Sat Feb 26 14:13:33 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200602, encodeId=dee112006026c, content=投稿2个半月，中间一次小修，accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39175593073, createdName=ms5000001819218664, createdTime=Tue Mar 08 16:15:06 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190195, encodeId=1c9e119019597, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：神经精神影像学 经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。 04 Feb 2022 Article accepted for publication. 03 Feb 2022 Review of Review Editor 2 finalized. 31 Jan 2022 Review of Review Editor 1 finalized. 29 Jan 2022 Corresponding Author ** re-submitted manuscript. 24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天 10 Nov 2021Corresponding Author ** submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220202/877149a0c31f433fb29e7e0ad849f4c0/076ec8880d2a478993563d85f21dae82.jpeg, createdBy=e98a2514828, createdName=pancs29, createdTime=Fri Feb 04 20:52:52 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196570, encodeId=6d7411965e069, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：已投8个月正在等消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c6b5611531, createdName=ms7000001135629356, createdTime=Wed Feb 23 21:49:27 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106075, encodeId=a63e11060e510, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106076, encodeId=af9e11060e6fb, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010343, encodeId=cbd01010343ad, content=求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5a2c5489227, createdName=ms9000001593769691, createdTime=Sun Aug 22 17:33:44 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007394, encodeId=4a2d100e394e3, content=偏重的研究方向：神经退行性疾病 经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bvIkMsUBo7h2qaicVFV7oRagNUor8OeO6wC7Zow0aSjmWbRwvGicHEmdWdPIibT5BcYT7DKhBGEQiagcgJ6v2XnH1A/132, createdBy=64172388588, createdName=Lewin, createdTime=Thu Aug 12 20:58:56 CST 2021, time=2021-08-12, status=1, ipAttribution=)]

2022-02-26 124b241fm93(暂无昵称)

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：神经退行性病变
经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。

64 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1231567, encodeId=76a5123156ecb, content=这个一次修改大概给多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4e8152487, createdName=ms2000000736224610, createdTime=Sun Jul 10 00:25:25 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015566, encodeId=de9c1015566da, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：呼吸神经调控 经验分享：7月14日，投稿另一个杂志 7月21日，根据建议投稿本刊，开始Review 8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修 9月2日，Review结束 9月7日，接收。总体速度很快，编辑也很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8895545547, createdName=ms5000000031838810, createdTime=Wed Sep 08 09:08:33 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197480, encodeId=d401119e48076, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：神经退行性病变 经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86902507861, createdName=124b241fm93(暂无昵称), createdTime=Sat Feb 26 14:13:33 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200602, encodeId=dee112006026c, content=投稿2个半月，中间一次小修，accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39175593073, createdName=ms5000001819218664, createdTime=Tue Mar 08 16:15:06 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190195, encodeId=1c9e119019597, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：神经精神影像学 经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。 04 Feb 2022 Article accepted for publication. 03 Feb 2022 Review of Review Editor 2 finalized. 31 Jan 2022 Review of Review Editor 1 finalized. 29 Jan 2022 Corresponding Author ** re-submitted manuscript. 24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天 10 Nov 2021Corresponding Author ** submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220202/877149a0c31f433fb29e7e0ad849f4c0/076ec8880d2a478993563d85f21dae82.jpeg, createdBy=e98a2514828, createdName=pancs29, createdTime=Fri Feb 04 20:52:52 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196570, encodeId=6d7411965e069, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：已投8个月正在等消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c6b5611531, createdName=ms7000001135629356, createdTime=Wed Feb 23 21:49:27 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106075, encodeId=a63e11060e510, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106076, encodeId=af9e11060e6fb, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010343, encodeId=cbd01010343ad, content=求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5a2c5489227, createdName=ms9000001593769691, createdTime=Sun Aug 22 17:33:44 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007394, encodeId=4a2d100e394e3, content=偏重的研究方向：神经退行性疾病 经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bvIkMsUBo7h2qaicVFV7oRagNUor8OeO6wC7Zow0aSjmWbRwvGicHEmdWdPIibT5BcYT7DKhBGEQiagcgJ6v2XnH1A/132, createdBy=64172388588, createdName=Lewin, createdTime=Thu Aug 12 20:58:56 CST 2021, time=2021-08-12, status=1, ipAttribution=)]

2022-03-08 ms5000001819218664

投稿2个半月，中间一次小修，accepted

51 0

[GetPortalCommentsPageByObjectIdResponse(id=1231567, encodeId=76a5123156ecb, content=这个一次修改大概给多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4e8152487, createdName=ms2000000736224610, createdTime=Sun Jul 10 00:25:25 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015566, encodeId=de9c1015566da, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：呼吸神经调控 经验分享：7月14日，投稿另一个杂志 7月21日，根据建议投稿本刊，开始Review 8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修 9月2日，Review结束 9月7日，接收。总体速度很快，编辑也很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8895545547, createdName=ms5000000031838810, createdTime=Wed Sep 08 09:08:33 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197480, encodeId=d401119e48076, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：神经退行性病变 经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86902507861, createdName=124b241fm93(暂无昵称), createdTime=Sat Feb 26 14:13:33 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200602, encodeId=dee112006026c, content=投稿2个半月，中间一次小修，accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39175593073, createdName=ms5000001819218664, createdTime=Tue Mar 08 16:15:06 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190195, encodeId=1c9e119019597, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：神经精神影像学 经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。 04 Feb 2022 Article accepted for publication. 03 Feb 2022 Review of Review Editor 2 finalized. 31 Jan 2022 Review of Review Editor 1 finalized. 29 Jan 2022 Corresponding Author ** re-submitted manuscript. 24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天 10 Nov 2021Corresponding Author ** submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220202/877149a0c31f433fb29e7e0ad849f4c0/076ec8880d2a478993563d85f21dae82.jpeg, createdBy=e98a2514828, createdName=pancs29, createdTime=Fri Feb 04 20:52:52 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196570, encodeId=6d7411965e069, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：已投8个月正在等消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c6b5611531, createdName=ms7000001135629356, createdTime=Wed Feb 23 21:49:27 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106075, encodeId=a63e11060e510, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106076, encodeId=af9e11060e6fb, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010343, encodeId=cbd01010343ad, content=求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5a2c5489227, createdName=ms9000001593769691, createdTime=Sun Aug 22 17:33:44 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007394, encodeId=4a2d100e394e3, content=偏重的研究方向：神经退行性疾病 经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bvIkMsUBo7h2qaicVFV7oRagNUor8OeO6wC7Zow0aSjmWbRwvGicHEmdWdPIibT5BcYT7DKhBGEQiagcgJ6v2XnH1A/132, createdBy=64172388588, createdName=Lewin, createdTime=Thu Aug 12 20:58:56 CST 2021, time=2021-08-12, status=1, ipAttribution=)]

2022-02-04 pancs29

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：神经精神影像学
经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。
04 Feb 2022 Article accepted for publication.
03 Feb 2022 Review of Review Editor 2 finalized.
31 Jan 2022 Review of Review Editor 1 finalized.
29 Jan 2022 Corresponding Author ** re-submitted manuscript.
24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天
10 Nov 2021Corresponding Author ** submitted manuscript.

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1231567, encodeId=76a5123156ecb, content=这个一次修改大概给多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4e8152487, createdName=ms2000000736224610, createdTime=Sun Jul 10 00:25:25 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015566, encodeId=de9c1015566da, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：呼吸神经调控 经验分享：7月14日，投稿另一个杂志 7月21日，根据建议投稿本刊，开始Review 8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修 9月2日，Review结束 9月7日，接收。总体速度很快，编辑也很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8895545547, createdName=ms5000000031838810, createdTime=Wed Sep 08 09:08:33 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197480, encodeId=d401119e48076, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：神经退行性病变 经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86902507861, createdName=124b241fm93(暂无昵称), createdTime=Sat Feb 26 14:13:33 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200602, encodeId=dee112006026c, content=投稿2个半月，中间一次小修，accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39175593073, createdName=ms5000001819218664, createdTime=Tue Mar 08 16:15:06 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190195, encodeId=1c9e119019597, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：神经精神影像学 经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。 04 Feb 2022 Article accepted for publication. 03 Feb 2022 Review of Review Editor 2 finalized. 31 Jan 2022 Review of Review Editor 1 finalized. 29 Jan 2022 Corresponding Author ** re-submitted manuscript. 24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天 10 Nov 2021Corresponding Author ** submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220202/877149a0c31f433fb29e7e0ad849f4c0/076ec8880d2a478993563d85f21dae82.jpeg, createdBy=e98a2514828, createdName=pancs29, createdTime=Fri Feb 04 20:52:52 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196570, encodeId=6d7411965e069, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：已投8个月正在等消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c6b5611531, createdName=ms7000001135629356, createdTime=Wed Feb 23 21:49:27 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106075, encodeId=a63e11060e510, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106076, encodeId=af9e11060e6fb, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010343, encodeId=cbd01010343ad, content=求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5a2c5489227, createdName=ms9000001593769691, createdTime=Sun Aug 22 17:33:44 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007394, encodeId=4a2d100e394e3, content=偏重的研究方向：神经退行性疾病 经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bvIkMsUBo7h2qaicVFV7oRagNUor8OeO6wC7Zow0aSjmWbRwvGicHEmdWdPIibT5BcYT7DKhBGEQiagcgJ6v2XnH1A/132, createdBy=64172388588, createdName=Lewin, createdTime=Thu Aug 12 20:58:56 CST 2021, time=2021-08-12, status=1, ipAttribution=)]

2022-02-23 ms7000001135629356

审稿速度:12.0 | 投稿命中率:50.0
经验分享：已投8个月正在等消息

56 0

[GetPortalCommentsPageByObjectIdResponse(id=1231567, encodeId=76a5123156ecb, content=这个一次修改大概给多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4e8152487, createdName=ms2000000736224610, createdTime=Sun Jul 10 00:25:25 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015566, encodeId=de9c1015566da, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：呼吸神经调控 经验分享：7月14日，投稿另一个杂志 7月21日，根据建议投稿本刊，开始Review 8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修 9月2日，Review结束 9月7日，接收。总体速度很快，编辑也很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8895545547, createdName=ms5000000031838810, createdTime=Wed Sep 08 09:08:33 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197480, encodeId=d401119e48076, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：神经退行性病变 经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86902507861, createdName=124b241fm93(暂无昵称), createdTime=Sat Feb 26 14:13:33 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200602, encodeId=dee112006026c, content=投稿2个半月，中间一次小修，accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39175593073, createdName=ms5000001819218664, createdTime=Tue Mar 08 16:15:06 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190195, encodeId=1c9e119019597, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：神经精神影像学 经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。 04 Feb 2022 Article accepted for publication. 03 Feb 2022 Review of Review Editor 2 finalized. 31 Jan 2022 Review of Review Editor 1 finalized. 29 Jan 2022 Corresponding Author ** re-submitted manuscript. 24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天 10 Nov 2021Corresponding Author ** submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220202/877149a0c31f433fb29e7e0ad849f4c0/076ec8880d2a478993563d85f21dae82.jpeg, createdBy=e98a2514828, createdName=pancs29, createdTime=Fri Feb 04 20:52:52 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196570, encodeId=6d7411965e069, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：已投8个月正在等消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c6b5611531, createdName=ms7000001135629356, createdTime=Wed Feb 23 21:49:27 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106075, encodeId=a63e11060e510, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106076, encodeId=af9e11060e6fb, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010343, encodeId=cbd01010343ad, content=求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5a2c5489227, createdName=ms9000001593769691, createdTime=Sun Aug 22 17:33:44 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007394, encodeId=4a2d100e394e3, content=偏重的研究方向：神经退行性疾病 经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bvIkMsUBo7h2qaicVFV7oRagNUor8OeO6wC7Zow0aSjmWbRwvGicHEmdWdPIibT5BcYT7DKhBGEQiagcgJ6v2XnH1A/132, createdBy=64172388588, createdName=Lewin, createdTime=Thu Aug 12 20:58:56 CST 2021, time=2021-08-12, status=1, ipAttribution=)]

2021-12-29 MS54455111222

通讯作者最多有多少个？同第一作者最多有多少个？

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1231567, encodeId=76a5123156ecb, content=这个一次修改大概给多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4e8152487, createdName=ms2000000736224610, createdTime=Sun Jul 10 00:25:25 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015566, encodeId=de9c1015566da, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：呼吸神经调控 经验分享：7月14日，投稿另一个杂志 7月21日，根据建议投稿本刊，开始Review 8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修 9月2日，Review结束 9月7日，接收。总体速度很快，编辑也很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8895545547, createdName=ms5000000031838810, createdTime=Wed Sep 08 09:08:33 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197480, encodeId=d401119e48076, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：神经退行性病变 经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86902507861, createdName=124b241fm93(暂无昵称), createdTime=Sat Feb 26 14:13:33 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200602, encodeId=dee112006026c, content=投稿2个半月，中间一次小修，accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39175593073, createdName=ms5000001819218664, createdTime=Tue Mar 08 16:15:06 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190195, encodeId=1c9e119019597, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：神经精神影像学 经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。 04 Feb 2022 Article accepted for publication. 03 Feb 2022 Review of Review Editor 2 finalized. 31 Jan 2022 Review of Review Editor 1 finalized. 29 Jan 2022 Corresponding Author ** re-submitted manuscript. 24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天 10 Nov 2021Corresponding Author ** submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220202/877149a0c31f433fb29e7e0ad849f4c0/076ec8880d2a478993563d85f21dae82.jpeg, createdBy=e98a2514828, createdName=pancs29, createdTime=Fri Feb 04 20:52:52 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196570, encodeId=6d7411965e069, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：已投8个月正在等消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c6b5611531, createdName=ms7000001135629356, createdTime=Wed Feb 23 21:49:27 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106075, encodeId=a63e11060e510, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106076, encodeId=af9e11060e6fb, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010343, encodeId=cbd01010343ad, content=求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5a2c5489227, createdName=ms9000001593769691, createdTime=Sun Aug 22 17:33:44 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007394, encodeId=4a2d100e394e3, content=偏重的研究方向：神经退行性疾病 经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bvIkMsUBo7h2qaicVFV7oRagNUor8OeO6wC7Zow0aSjmWbRwvGicHEmdWdPIibT5BcYT7DKhBGEQiagcgJ6v2XnH1A/132, createdBy=64172388588, createdName=Lewin, createdTime=Thu Aug 12 20:58:56 CST 2021, time=2021-08-12, status=1, ipAttribution=)]

2021-12-27 rayms

作者可以写中文名么？

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1231567, encodeId=76a5123156ecb, content=这个一次修改大概给多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4e8152487, createdName=ms2000000736224610, createdTime=Sun Jul 10 00:25:25 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015566, encodeId=de9c1015566da, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：呼吸神经调控 经验分享：7月14日，投稿另一个杂志 7月21日，根据建议投稿本刊，开始Review 8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修 9月2日，Review结束 9月7日，接收。总体速度很快，编辑也很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8895545547, createdName=ms5000000031838810, createdTime=Wed Sep 08 09:08:33 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197480, encodeId=d401119e48076, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：神经退行性病变 经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86902507861, createdName=124b241fm93(暂无昵称), createdTime=Sat Feb 26 14:13:33 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200602, encodeId=dee112006026c, content=投稿2个半月，中间一次小修，accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39175593073, createdName=ms5000001819218664, createdTime=Tue Mar 08 16:15:06 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190195, encodeId=1c9e119019597, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：神经精神影像学 经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。 04 Feb 2022 Article accepted for publication. 03 Feb 2022 Review of Review Editor 2 finalized. 31 Jan 2022 Review of Review Editor 1 finalized. 29 Jan 2022 Corresponding Author ** re-submitted manuscript. 24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天 10 Nov 2021Corresponding Author ** submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220202/877149a0c31f433fb29e7e0ad849f4c0/076ec8880d2a478993563d85f21dae82.jpeg, createdBy=e98a2514828, createdName=pancs29, createdTime=Fri Feb 04 20:52:52 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196570, encodeId=6d7411965e069, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：已投8个月正在等消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c6b5611531, createdName=ms7000001135629356, createdTime=Wed Feb 23 21:49:27 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106075, encodeId=a63e11060e510, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106076, encodeId=af9e11060e6fb, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010343, encodeId=cbd01010343ad, content=求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5a2c5489227, createdName=ms9000001593769691, createdTime=Sun Aug 22 17:33:44 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007394, encodeId=4a2d100e394e3, content=偏重的研究方向：神经退行性疾病 经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bvIkMsUBo7h2qaicVFV7oRagNUor8OeO6wC7Zow0aSjmWbRwvGicHEmdWdPIibT5BcYT7DKhBGEQiagcgJ6v2XnH1A/132, createdBy=64172388588, createdName=Lewin, createdTime=Thu Aug 12 20:58:56 CST 2021, time=2021-08-12, status=1, ipAttribution=)]

2021-08-22 ms9000001593769691

求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的

66 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1231567, encodeId=76a5123156ecb, content=这个一次修改大概给多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd4e8152487, createdName=ms2000000736224610, createdTime=Sun Jul 10 00:25:25 CST 2022, time=2022-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015566, encodeId=de9c1015566da, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2950.0 偏重的研究方向：呼吸神经调控 经验分享：7月14日，投稿另一个杂志 7月21日，根据建议投稿本刊，开始Review 8月20日，Review回来，2个Reviewer都很专业，其中一个也做的我们的研究方向，建议小修 9月2日，Review结束 9月7日，接收。总体速度很快，编辑也很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8895545547, createdName=ms5000000031838810, createdTime=Wed Sep 08 09:08:33 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197480, encodeId=d401119e48076, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：神经退行性病变 经验分享：这个杂志的审稿模式真的让人琢磨不透，去年10月13号投稿，10月21号外审，11月14号reviewer 2给了小修，修回后1周，endorsed. 11月17号reviewer 1退出，这样只有一个reviewer 2了。这样中间隔了一个多月，一直到12月20号，副主编又给找了个reviewer 3. 现在过去两个多月reviewer 3 一直是pending，整个投稿周期已经4个半月，给编辑部和副主编发邮件也没人回。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=86902507861, createdName=124b241fm93(暂无昵称), createdTime=Sat Feb 26 14:13:33 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200602, encodeId=dee112006026c, content=投稿2个半月，中间一次小修，accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39175593073, createdName=ms5000001819218664, createdTime=Tue Mar 08 16:15:06 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190195, encodeId=1c9e119019597, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：神经精神影像学 经验分享：杂志效率很高，只不过本人研究的小领域比较冷门，找审稿人花了很久，后续流程顺畅。 04 Feb 2022 Article accepted for publication. 03 Feb 2022 Review of Review Editor 2 finalized. 31 Jan 2022 Review of Review Editor 1 finalized. 29 Jan 2022 Corresponding Author ** re-submitted manuscript. 24 Jan 2022 Interactive review forum activated. 两个意见均为minor，小修限时7天 10 Nov 2021Corresponding Author ** submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220202/877149a0c31f433fb29e7e0ad849f4c0/076ec8880d2a478993563d85f21dae82.jpeg, createdBy=e98a2514828, createdName=pancs29, createdTime=Fri Feb 04 20:52:52 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196570, encodeId=6d7411965e069, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：已投8个月正在等消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c6b5611531, createdName=ms7000001135629356, createdTime=Wed Feb 23 21:49:27 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106075, encodeId=a63e11060e510, content=通讯作者最多有多少个？同第一作者最多有多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106076, encodeId=af9e11060e6fb, content=作者可以写中文名么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010343, encodeId=cbd01010343ad, content=求助，投稿三个月，一直是independent review，也没有显示review is ongoing 啥的，历史列表里只显示我在哪天投稿成功，现在这是属于什么阶段呀，给编辑写了催稿信没有回复，请问有没有过类似经历的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5a2c5489227, createdName=ms9000001593769691, createdTime=Sun Aug 22 17:33:44 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007394, encodeId=4a2d100e394e3, content=偏重的研究方向：神经退行性疾病 经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bvIkMsUBo7h2qaicVFV7oRagNUor8OeO6wC7Zow0aSjmWbRwvGicHEmdWdPIibT5BcYT7DKhBGEQiagcgJ6v2XnH1A/132, createdBy=64172388588, createdName=Lewin, createdTime=Thu Aug 12 20:58:56 CST 2021, time=2021-08-12, status=1, ipAttribution=)]

2021-08-12 Lewin

偏重的研究方向：神经退行性疾病
经验分享：投过两次，对编辑十分不满意！第一次去年11月底投稿，2个reviewer在今年1月份就写好审稿意见了，不负责的编辑拖到8月份，然后有一个reviewer变成inactive了，缺一个审稿人他又不积极去找，然后给我rejected了🤬🤬🤬 第二次投稿是今年2月底，然后一直找不到合适的reviewer，最后后台让我自己推荐5个人，又拖到7月底三个reviewer给了minor revision，8月初修回去，4个小时后三个reviewer都endorsed了，退了10多天副主编都没有最初decision.😓😓😓 这个系列的杂志，副主编很关键，他的办事效率完全决定了你稿件的接受时间…

75 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务